Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter - Avience Biomedicals LimitedNSE · exchange filing · pdf
Source filing Company dossier
Avience Biomedicals
NSE:AVIENCE · ISIN INE0V9I01017
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Avience Biomedicals
Filings
Preserved evidence
11 recent eventsPrimary-source filing timeline
Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Avience Biomedicals LimitedNSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Avience Biomedicals LimitedNSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Avience Biomedicals LimitedNSE · conference call · pdf
Source filing Updates - Avience Biomedicals LimitedNSE · financial results · pdf
Archived filing Analysts/Institutional Investor Meet/Con. Call Updates - Avience Biomedicals LimitedNSE · conference call · pdf
Source filing Investor Presentation - Avience Biomedicals LimitedNSE · investor presentation · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Avience Biomedicals LimitedNSE · conference call · pdf
Source filing Integrated Filing- Financials attachment - Avience Biomedicals LimitedNSE · integrated filing attachment · pdf
Archived filing Outcome of Board Meeting - Avience Biomedicals LimitedNSE · financial results · pdf
Source filing Integrated Filing- Financials attachment - Avience Biomedicals LimitedNSE · integrated filing attachment · pdf
Archived filing